Efficacy, Safety and Predictive Factors for Outcomes and Adverse Events in Sclerotherapy for Venous Malformations in Children
Topic overview
This study evaluates polidocanol sclerotherapy outcomes in pediatric patients with venous malformations, addressing a gap in pediatric-specific data. The research examines treatment efficacy, safety profiles, and identifies predictive factors for both successful outcomes and adverse events in this young population.
Key takeaways
- Percutaneous sclerotherapy is an established treatment for venous malformations but pediatric data remain limited.
- This study evaluates polidocanol-based sclerotherapy efficacy and safety specifically in children with venous malformations.
- The research identifies predictive factors for both clinical outcomes and adverse events in pediatric sclerotherapy patients.
- Polidocanol is the sclerosing agent of choice, requiring outcome data to optimize pediatric treatment protocols.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Efficacy, Safety and Predictive Factors for Outcomes and Adverse Events in Sclerotherapy for Venous Malformations in Children. GlobalCastMD Medical Library. 2025-10-23. https://library.globalcastmd.com/article/11150
Comments